|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A facility location allocation model for reusing carpet material显示文摘 | Kip BJ Peters E | 1999 | Computers & Industrial Engineering1999，36，4： | 1 |
| 2 | Along-termst study of the arti-inflammatory effct of 10w-dost bujesonide plus formoterol versus high-dosc budesonide in asthma显示文摘 | Kips JC O Connor BJ Imnan MD | 2000 | DmJKespir Crit Care med2000，161，： | 1 |
| 3 | A facility location allocation model for re-using carpet materials 显示文摘 | Louwers D Kip BJ Peters E | 1999 | Computers and Industrial Engineering1999，36，4： | 1 |
| 4 | A long-term study of the arti-inflammatory effct of 10w-dose budesonide plus formoterol versus high-dose budesonide in asthma显示文摘 | Kips JC O Connor BJ Inman MD | 2000 | Dm J Respir Crit Care Med2000，161，： | 1 |
| 5 | Effect of SCH55700,a humanized anti-human interleukin-5 antibody,in severe persistent asthma:a pilot study显示文摘 | Kips JC O'Connor BJ Langley SJ | 2003 | Am J Respir Crit Care Med2003，167，12： | 1 |
| 6 | A long-term study of the anti inflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma 显示文摘 | Kips JC O′Connor BJ Inman MD | 2000 | Am J Respir Crit Care Med2000，161，31： | 1 |
| 7 | A long-term study of the antinflammat ory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma显示文摘 | KIPS JC O'CONNOR BJ INMAN MD | 2000 | Am J Respir Crit Care Med2000，161，31： | 1 |
| 8 | A facility location allocation model for re-using carpet materials显示文摘 | LOUWERS D KIP BJ PETERS E SOUREN F FLAPPER SDP | 1999 | Computers and Industrial Engineering1999，，36： | 1 |
| 9 | A Facility Location Allocation Model for Re-using Capet Materials显示文摘 | ouwers D Kip BJ peters E Souren F etal | 1999 | Computers and Industrial Engineering1999，36，4： | 1 |
| 10 | Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study显示文摘 | Kips JC O'Connor BJ Langley SJ | 2003 | Am J Respir Crit Care Med2003，167，12： | 1 |
| 11 | Effect of SCH55700,a humanized anti-human interleukin-5 antibody,in severe persistent asthma:a pilot study显示文摘 | Kips JC O'Connor BJ Langley SJ | 2003 | Am J Respir Crit Care Med2003，167，12： | 1 |
| 12 | Along-term study of the anti-inflammatory effect of low-dose budesonide plus formoterol versus high-dosebudesonide in asthma显示文摘 | Kips JC O Connor BJ Inman MD | 2000 | Am J Respir Crit Care Med2000，161，： | 1 |
| 13 | A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma显示文摘 | Kip J C O' Connor BJ Inman MD Svensson K Pauwels RA O'Byren PM | 2000 | Am J Respir Crit Care Med2000，161，： | 1 |
| 14 | A long-term study of the anti-inflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma显示文摘 | Oconnor BJ Inman MD | 2000 | Am J Respir Crit Care Med2000，161，： | 1 |
| 15 | Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study 显示文摘 | Kips JC O'Connor BJ Langley SJ | 2003 | Am J Respir Crit Care Med2003，167，12： | 1 |
| 16 | Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study显示文摘 | Kips JC O' Cormor BJ Langley SJ | 2003 | Am J Respir Cfit Care Med2003，167，12： | 1 |
| 17 | A facility location allocation model for reusing carpet materials显示文摘 | Louwers D Kip BJ Peter E Souren F Flapper SDP | 1999 | Computer and Industrial Engineering1999，36，4： | 1 |
| 18 | A Facility Location Allocation Model for Re-using Carpet Materials显示文摘 | Louwers D Kip BJ Peters E | 1999 | Computers and Industrial Engineering1999，36，4： | 1 |
| 19 | A long-term,study of the antiinflmmatory effect of low - dose budesonide plus formoterol versus high-dose budesonide in asthma显示文摘 | Kips JC O'eonnor BJ Inman Md | 2000 | Am J Respir Crit Care Med2000，161，3： | 1 |
| 20 | A long-term,study of the antiinflmmatory effect of low-dose budesonide plus formoterol versus high-dose bydesibude ub astgna显示文摘 | Kips JC M O'onnor BJ Inman MD | 2000 | Am J Respir Crit Care Med2000，161，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员